A New Modified Experimental Meibomian Gland Injury Model: Partial Loss of Gland Due to Orifice Cauterization and the Alleviating Potential of 22-Oxacalcitriol

1α,-25-dihydroxy-22-oxacalcitriol (maxacalcitol) is a non-calcemic vitamin D3 analog clinically approved to treat psoriasis, and its role has been increasingly recognized in suppressing keratinocyte proliferation, mediating inflammation, and regulating the immune response. A large number of studies...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Kai, Kawashima, Motoko, Ito, Masataka, Arita, Reiko, Sano, Kokoro, Tsubota, Kazuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792963/
https://www.ncbi.nlm.nih.gov/pubmed/33375143
http://dx.doi.org/10.3390/jcm10010006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792963/
https://www.ncbi.nlm.nih.gov/pubmed/33375143
http://dx.doi.org/10.3390/jcm10010006

Ejemplares similares